Hester Biosciences Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HESTERBIO.NS | EBS | 300601.SZ | 300199.SZ | ZTS | CJH.F | |
|---|---|---|---|---|---|---|
| Market cap | — | 306.31M | 14.41B | 21.97B | 35.17B | 755.95M |
| P/E (TTM) | 15.0 | — | 117.3 | 55.3 | 14.0 | 153.0 |
| Forward P/E | — | 5.7 | 45.0 | 82.9 | 13.3 | — |
| Price/book | 5.7 | 1.0 | 1.5 | 20.5 | 11.2 | 1.1 |
| Dividend yield | 0.48% | — | 0.49% | — | 2.38% | — |
| 1-year change | +45.28% | −42.55% | −24.67% | +9.03% | −25.39% | −41.70% |
| Today | +4.12% | +0.89% | +1.57% | +9.51% | −4.60% | +6.25% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All HESTERBIO.NS news ›Hester Biosciences approves ₹10.50 million investment in Slyce Agri World
Hester Biosciences has approved an investment of up to ₹10.50 million in Slyce Agri World LLP, directed toward renewable energy. The approved investment will represent 26% of Slyce Agri World LLP's total fixed capital, making Hester…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- scanx.trade1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.